Aptorum Group Limited

2.34 USD
+0.53 (+29.28%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Aptorum Group Limited stock is up 49.04% since 30 days ago. The next earnings date is Apr 26, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 5 February’s closed higher than January.

About Aptorum Group Limited

Aptorum Group Limited engages in the discovery, development, and commercialization of therapeutic products. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules. The company also focuses on therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas.